{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:12:41Z","timestamp":1790838761658,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T00:00:00Z","timestamp":1509926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T00:00:00Z","timestamp":1509926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Liver failure, whether arising directly from acute liver failure or from decompensated chronic liver disease is an increasing problem worldwide and results in many deaths. In the UK only 10% of individuals requiring a liver transplant receive one. Thus the need for alternative treatments is paramount. A BioArtificial Liver machine could temporarily replace the functions of the liver, buying time for the patient\u2019s liver to repair and regenerate. We have designed, implemented and tested a clinical-scale BioArtificial Liver machine containing a biomass derived from a hepatoblastoma cell-line cultured as three dimensional organoids, using a fluidised bed bioreactor, together with single-use bioprocessing equipment, with complete control of nutrient provision with feedback BioXpert recipe processes, and yielding good phenotypic liver functions. The methodology has been designed to meet specifications for GMP production, required for manufacture of advanced therapy medicinal products (ATMPs). In a porcine model of severe liver failure, damage was assured in all animals by surgical ischaemia in pigs with human sized livers (1.2\u20131.6\u2009kg liver weights). The BioArtificial liver (UCLBAL) improved important prognostic clinical liver-related parameters, eg, a significant improvement in coagulation, reduction in vasopressor requirements, improvement in blood pH and in parameters of intracranial pressure (ICP) and oxygenation.<\/jats:p>","DOI":"10.1038\/s41598-017-15021-4","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T06:29:01Z","timestamp":1509431341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["A clinical-scale BioArtificial Liver, developed for GMP, improved clinical parameters of liver function in porcine liver failure"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2648-443X","authenticated-orcid":false,"given":"Clare","family":"Selden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloy","family":"Erro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Puschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delawir","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humphrey","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Gonzalez-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Le Lay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kilbride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ginsburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Ilsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galya","family":"Chinnery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8482-0847","authenticated-orcid":false,"given":"Ncedile","family":"Mankahla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizel","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Wendy","family":"Spearman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,6]]},"reference":[{"key":"15021_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1749-6632.1999.tb08517.x","volume":"875","author":"C Selden","year":"1999","unstructured":"Selden, C. et al. Three-dimensional in vitro cell culture leads to a marked upregulation of cell function in human hepatocyte cell lines\u2013an important tool for the development of a bioartificial liver machine. Ann. N. Y. Acad. Sci \n                           875, 353\u2013363 (1999).","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"15021_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0168-8278(00)00080-5","volume":"34","author":"M Khalil","year":"2001","unstructured":"Khalil, M. et al. Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly upregulate both synthetic and detoxificatory liver function. J. Hepatol \n                           34, 68\u201377 (2001).","journal-title":"J. Hepatol"},{"key":"15021_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/biores.2012.0286","volume":"2","author":"E Erro","year":"2013","unstructured":"Erro, E. et al. Bioengineering the liver: scale-up and cool chain delivery of the liver cell biomass for clinical targeting in a bioartificial liver support system. BioResearch Open Access \n                           2, 1\u201311 (2013).","journal-title":"BioResearch Open Access"},{"key":"15021_CR4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/j.1525-1594.2009.00821.x","volume":"33","author":"SM Coward","year":"2009","unstructured":"Coward, S. M. et al. Alginate-encapsulated HepG2 cells in a fluidized bed bioreactor maintain function in human liver failure plasma. Artif Organs \n                           33, 1117\u20131126 (2009).","journal-title":"Artif Organs"},{"key":"15021_CR5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/0002-9610(75)90323-2","volume":"129","author":"TE Starzl","year":"1975","unstructured":"Starzl, T. E., Putnam, C. W., Groth, C. G., Corman, J. L. & Taubman, J. Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection. Am. J Surg \n                           129, 587\u2013590 (1975).","journal-title":"Am. J Surg"},{"key":"15021_CR6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1177\/039139880602900805","volume":"29","author":"B David","year":"2006","unstructured":"David, B., Barbe, L., Barthes-Biesel, D. & Legallais, C. Mechanical properties of alginate beads hosting hepatocytes in a fluidized bed bioreactor. Int. J Artif Organs \n                           29, 756\u2013763 (2006).","journal-title":"Int. J Artif Organs"},{"key":"15021_CR7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/039139880402700404","volume":"27","author":"B David","year":"2004","unstructured":"David, B., Dore, E., Jaffrin, M. Y. & Legallais, C. Mass transfers in a fluidized bed bioreactor using alginate beads for a future bioartificial liver. Int. J Artif Organs \n                           27, 284\u2013293 (2004).","journal-title":"Int. J Artif Organs"},{"key":"15021_CR8","doi-asserted-by":"publisher","first-page":"e82312","DOI":"10.1371\/journal.pone.0082312","volume":"8","author":"C Selden","year":"2013","unstructured":"Selden, C. et al. Evaluation of encapsulated liver cell spheroids in a fluidised-bed bioartificial liver for treatment of ischaemic acute liver failure in pigs in a translational setting. PLoS. One \n                           8, e82312, https:\/\/doi.org\/10.1371\/journal.pone.0082312 (2013).","journal-title":"PLoS. One"},{"key":"15021_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00595-003-2599-y","volume":"33","author":"T Miyashita","year":"2003","unstructured":"Miyashita, T. et al. Standardization of ischemic hepatic failure in pigs as a model for bioartificial liver assessment. Surg. Today \n                           33, 743\u2013750 (2003).","journal-title":"Surg. Today"},{"key":"15021_CR10","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1227\/01.NEU.0000333265.19131.7C","volume":"63","author":"C Stewart","year":"2008","unstructured":"Stewart, C. et al. The new Licox combined brain tissue oxygen and brain temperature monitor: assessment of in vitro accuracy and clinical experience in severe traumatic brain injury. Neurosurgery \n                           63, 1159\u20131164 (2008).","journal-title":"Neurosurgery"},{"key":"15021_CR11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1177\/039139880002301107","volume":"23","author":"C Selden","year":"2000","unstructured":"Selden, C., Khalil, M. & Hodgson, H. Three dimensional culture upregulates extracellular matrix protein expression in human liver cell lines\u2013a step towards mimicking the liver in vivo? Int. J. Artif. Organs \n                           23, 774\u2013781 (2000).","journal-title":"Int. J. Artif. Organs"},{"key":"15021_CR12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/039139880502800611","volume":"28","author":"MP van de Kerkhove","year":"2005","unstructured":"van de Kerkhove, M. P. et al. Assessment and improvement of liver specific function of the AMC-bioartificial liver. Int J Artif Organs \n                           28, 617\u2013630 (2005).","journal-title":"Int J Artif Organs"},{"key":"15021_CR13","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1002\/term.418","volume":"5","author":"D Mueller","year":"2011","unstructured":"Mueller, D. et al. In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor. J. Tissue Eng Regen. Med \n                           5, e207\u2013e218, https:\/\/doi.org\/10.1002\/term.418 (2011).","journal-title":"J. Tissue Eng Regen. Med"},{"key":"15021_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/biores.2012.0286","volume":"2","author":"E Erro","year":"2013","unstructured":"Erro, E. et al. Bioengineering the liver: scale-up and cool chain delivery of the liver cell biomass for clinical targeting in a bioartificial liver support system. Biores. Open. Access \n                           2, 1\u201311, https:\/\/doi.org\/10.1089\/biores.2012.0286 (2013).","journal-title":"Biores. Open. Access"},{"key":"15021_CR15","unstructured":"US Pharmacopeial Convention. USP General Chapter <788> Particulate Matter in Injections, downloaded 30th Sept 2016, http:\/\/www.usp.org\/sites\/default\/files\/usp_pdf\/EN\/USPNF\/revisionGeneralChapter788.pdf (2016)."},{"key":"15021_CR16","first-page":"348","volume":"57","author":"RD Hughes","year":"1976","unstructured":"Hughes, R. D., Cochrane, A. M., Thomson, A. D., Murray-Lyon, I. M. & Williams, R. The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. Br. J. Exp. Pathol \n                           57, 348\u2013353 (1976).","journal-title":"Br. J. Exp. Pathol"},{"key":"15021_CR17","doi-asserted-by":"crossref","unstructured":"Van Wenum, M. et al. Effects of healthy- and acute liver failure plasma on differentiated human heparg progenitor cells in monolayers and bioartificial livers. Journal Of Hepatology EASL The International Liver Congress Barcelona 2016 (ILC2016-RS-2410) (2016).","DOI":"10.1016\/S0168-8278(16)00406-2"},{"key":"15021_CR18","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1042\/bj0300762","volume":"30","author":"HN Naumann","year":"1936","unstructured":"Naumann, H. N. Studies on bile pigments: A new test for bilirubin in the urine and its use for detection of bilirubin in normal urine. Biochem. J \n                           30, 762\u2013764 (1936).","journal-title":"Biochem. J"},{"key":"15021_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1365-2044.2012.07101.x","volume":"67","author":"B Macafee","year":"2012","unstructured":"Macafee, B. et al. Reference ranges for thromboelastography (TEG((R))) and traditional coagulation tests in term parturients undergoing caesarean section under spinal anaesthesia*. Anaesthesia \n                           67, 741\u2013747, https:\/\/doi.org\/10.1111\/j.1365-2044.2012.07101.x (2012).","journal-title":"Anaesthesia"},{"key":"15021_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11011-005-7927-z","volume":"20","author":"M Belanger","year":"2005","unstructured":"Belanger, M. & Butterworth, R. F. Acute liver failure: a critical appraisal of available animal models. Metab Brain Dis \n                           20, 409\u2013423, https:\/\/doi.org\/10.1007\/s11011-005-7927-z (2005).","journal-title":"Metab Brain Dis"},{"key":"15021_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1046\/j.1365-2613.2000.00144.x","volume":"81","author":"TM Rahman","year":"2000","unstructured":"Rahman, T. M. & Hodgson, H. J. Animal models of acute hepatic failure. Int. J Exp. Pathol \n                           81, 145\u2013157 (2000).","journal-title":"Int. J Exp. Pathol"},{"key":"15021_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/cr.2016.6","volume":"26","author":"XL Shi","year":"2016","unstructured":"Shi, X. L. et al. Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes. Cell Res \n                           26, 206\u2013216, https:\/\/doi.org\/10.1038\/cr.2016.6 (2016).","journal-title":"Cell Res"},{"key":"15021_CR23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0168-8278(99)80285-2","volume":"31","author":"P McCloskey","year":"1999","unstructured":"McCloskey, P. et al. Resistance of three immortalized human hepatocyte cell lines to acetaminophen and N-acetyl-p-benzoquinoneimine toxicity. J Hepatol \n                           31, 841\u2013851 (1999).","journal-title":"J Hepatol"},{"key":"15021_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep26070","volume":"6","author":"P Zhou","year":"2016","unstructured":"Zhou, P. et al. Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study. Sci. Rep \n                           6, 26070, https:\/\/doi.org\/10.1038\/srep26070 (2016).","journal-title":"Sci. Rep"},{"key":"15021_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2500","author":"CT Nicolas","year":"2016","unstructured":"Nicolas, C. T. et al. Concise Review: Liver Regenerative Medicine: from Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts. Stem Cells. https:\/\/doi.org\/10.1002\/stem.2500 (2016).","journal-title":"Stem Cells"},{"key":"15021_CR26","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/01.sla.0000124298.74199.e5","volume":"239","author":"AA Demetriou","year":"2004","unstructured":"Demetriou, A. A. et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg \n                           239, 660\u2013667 (2004).","journal-title":"Ann. Surg"},{"key":"15021_CR27","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/j.1478-3231.2009.02087.x","volume":"29","author":"JH Fruhauf","year":"2009","unstructured":"Fruhauf, J. H., Mertsching, H. & Giri, S. Fr++ hauf, N. R. & Bader, A. Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells. Liver International \n                           29, 1553\u20131561 (2009).","journal-title":"Liver International"},{"key":"15021_CR28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1126\/science.aad1191","volume":"350","author":"L Yang","year":"2015","unstructured":"Yang, L. et al. Genome-wide inactivation of porcine endogenous retroviruses (PERVs). Science \n                           350, 1101\u20131104, https:\/\/doi.org\/10.1126\/science.aad1191 (2015).","journal-title":"Science"},{"key":"15021_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.biocel.2006.10.007","volume":"39","author":"D Mavri-Damelin","year":"2007","unstructured":"Mavri-Damelin, D. et al. Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2. Int J Biochem. Cell Biol \n                           39, 555\u2013564 (2007).","journal-title":"Int J Biochem. Cell Biol"},{"key":"15021_CR30","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/bit.21599","volume":"99","author":"D Mavri-Damelin","year":"2008","unstructured":"Mavri-Damelin, D. et al. Cells for bioartificial liver devices: The human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia. Biotechnology and Bioengineering \n                           99, 644\u2013651 (2008).","journal-title":"Biotechnology and Bioengineering"},{"key":"15021_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/bjs.1800197331","volume":"19","author":"O Warburg","year":"1931","unstructured":"Warburg, O. & Dickens, F. The metabolism of tumours. Investigations from the Kaiser-Wilhelm Institute for Biology, Berlin-Dahlem. Edited by Otto Warburg, Kaiser-Wilhelm Institute for Biology, Berlin-Dahlem. Translated from the German edition, with accounts of additional recent researches, by Frank Dickens, M.A., Ph.D., whole-time worker for the Medical Research Council, Courtauld Institute of Biochemistry, Middlesex Hospital, London. Demy 8vo. Pp. 327 + xxix. Illustrated. 1930. London: Constable & Co. Ltd. 40\u2009s. net. British Journal of Surgery \n                           19, 168\u2013168, https:\/\/doi.org\/10.1002\/bjs.1800197331 (1931).","journal-title":"British Journal of Surgery"},{"key":"15021_CR32","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.biocel.2011.06.011","volume":"43","author":"R Hoekstra","year":"2011","unstructured":"Hoekstra, R. et al. The HepaRG cell line is suitable for bioartificial liver application. Int J Biochem. Cell Biol \n                           43, 1483\u20131489 (2011).","journal-title":"Int J Biochem. Cell Biol"},{"key":"15021_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","volume":"168","author":"A Guillouzo","year":"2007","unstructured":"Guillouzo, A. et al. The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chemico-Biological Interactions \n                           168, 66\u201373 (2007).","journal-title":"Chemico-Biological Interactions"},{"key":"15021_CR34","doi-asserted-by":"publisher","first-page":"964","DOI":"10.7150\/ijbs.15165","volume":"12","author":"M Van Wenum","year":"2016","unstructured":"Van Wenum, M. et al. Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines. Int. J. Biol. Sci \n                           12, 964\u2013978, https:\/\/doi.org\/10.7150\/ijbs.15165 (2016).","journal-title":"Int. J. Biol. Sci"},{"key":"15021_CR35","doi-asserted-by":"crossref","unstructured":"Coward, S. M. et al. Alginate-Encapsulated HepG2 Cells in a Pilot-Scale Fluidised Bed Bioreactor Maintain Performance in Human Liver Failure Plasma Making Them Suitable for Use in a Bioartificial Liver. Artif Organs (2009).","DOI":"10.1111\/j.1525-1594.2009.00821.x"},{"key":"15021_CR36","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bph.13422","volume":"173","author":"B Bhattacharya","year":"2016","unstructured":"Bhattacharya, B., Mohd Omar, M. F. & Soong, R. The Warburg effect and drug resistance. British Journal of Pharmacology \n                           173, 970\u2013979, https:\/\/doi.org\/10.1111\/bph.13422 (2016).","journal-title":"British Journal of Pharmacology"},{"key":"15021_CR37","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","volume":"40","author":"D Lopez-Terrada","year":"2009","unstructured":"Lopez-Terrada, D., Cheung, S. W., Finegold, M. J. & Knowles, B. B. Hep G2 is a hepatoblastoma-derived cell line. Hum. Pathol \n                           40, 1512\u20131515, https:\/\/doi.org\/10.1016\/j.humpath.2009.07.003 (2009).","journal-title":"Hum. Pathol"},{"key":"15021_CR38","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2004.01.002","volume":"126","author":"R Parent","year":"2004","unstructured":"Parent, R., Marion, M. J., Furio, L., Trepo, C. & Petit, M. A. Origin and characterization of a human bipotent liver progenitor cell line. Gastroenterology \n                           126, 1147\u20131156, https:\/\/doi.org\/10.1053\/j.gastro.2004.01.002 (2004).","journal-title":"Gastroenterology"},{"key":"15021_CR39","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.5966\/sctm.2015-0235","volume":"5","author":"B Wang","year":"2016","unstructured":"Wang, B. et al. Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments. Stem Cells Transl. Med. \n                           5, 1257\u20131267, https:\/\/doi.org\/10.5966\/sctm.2015-0235 (2016).","journal-title":"Stem Cells Transl. Med."},{"key":"15021_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0011-9164(87)87013-3","volume":"62","author":"AG Fane","year":"1986","unstructured":"Fane, A. G. & Fell, C. J. D. A review of fouling and fouling control in ultrafiltration. Desalination \n                           62, 117\u2013136 (1986).","journal-title":"Desalination"},{"key":"15021_CR41","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/btpr.4","volume":"24","author":"M Stressmann","year":"2008","unstructured":"Stressmann, M. & Moresoli, C. Effect of pore size, shear rate, and harvest time during the constant permeate flux microfiltration of CHO cell culture supernatant. Biotechnol. Prog \n                           24, 890\u2013897, https:\/\/doi.org\/10.1002\/btpr.4 (2008).","journal-title":"Biotechnol. Prog"},{"key":"15021_CR42","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1046\/j.1525-1594.2003.07074.x","volume":"27","author":"Y Moussy","year":"2003","unstructured":"Moussy, Y. Convective flow through a hollow fiber bioartificial liver. Artif. Organs \n                           27, 1041\u20131049 (2003).","journal-title":"Artif. Organs"},{"key":"15021_CR43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1749-6632.2001.tb03845.x","volume":"944","author":"JM Macdonald","year":"2001","unstructured":"Macdonald, J. M., Wolfe, S. P., Roy-Chowdhury, I., Kubota, H. & Reid, L. M. Effect of flow configuration and membrane characteristics on membrane fouling in a novel multicoaxial hollow-fiber bioartificial liver. Ann. N. Y. Acad. Sci \n                           944, 334\u2013343 (2001).","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"15021_CR44","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1177\/039139880202501009","volume":"25","author":"MP van de Kerkhove","year":"2002","unstructured":"van de Kerkhove, M. P. et al. Phase I clinical trial with the AMC-bioartificial liver. Int. J Artif Organs \n                           25, 950\u2013959 (2002).","journal-title":"Int. J Artif Organs"},{"key":"15021_CR45","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/00000658-199705000-00005","volume":"225","author":"FD Watanabe","year":"1997","unstructured":"Watanabe, F. D. et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Annals of Surgery \n                           225, 484\u2013491 (1997).","journal-title":"Annals of Surgery"},{"key":"15021_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0376-7388(00)00539-1","volume":"181","author":"C Legallais","year":"2001","unstructured":"Legallais, C., David, B. & Dore, E. Bioartificial livers (BAL): current technological aspects and future developments. journal of membrane science \n                           181, 81\u201395 (2001).","journal-title":"journal of membrane science"},{"key":"15021_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.22203\/eCM.v021a08","volume":"21","author":"A Gautier","year":"2011","unstructured":"Gautier, A. et al. Impact of alginate type and bead diameter on mass transfers and the metabolic activities of encapsulated C3A cells in bioartificial liver applications. Eur. Cell Mater \n                           21, 94\u2013106, https:\/\/doi.org\/10.22203\/eCM.v021a08 (2011).","journal-title":"Eur. Cell Mater"},{"key":"15021_CR48","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1109\/EMBC.2015.7318615","volume":"2015","author":"S Figaro","year":"2015","unstructured":"Figaro, S. et al. Development and validation of a bioartificial liver device with fluidized bed bioreactors hosting alginate-encapsulated hepatocyte spheroids. Conf. Proc. IEEE Eng Med. Biol. Soc \n                           2015, 1335\u20131338, https:\/\/doi.org\/10.1109\/EMBC.2015.7318615 (2015).","journal-title":"Conf. Proc. IEEE Eng Med. Biol. Soc"},{"key":"15021_CR49","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5301\/ijao.5000567","volume":"40","author":"S Figaro","year":"2017","unstructured":"Figaro, S. et al. Optimizing the fluidized bed bioreactor as an external bioartificial liver. Int J Artif Organs \n                           40, 196\u2013203, https:\/\/doi.org\/10.5301\/ijao.5000567 (2017).","journal-title":"Int J Artif Organs"},{"key":"15021_CR50","first-page":"413","volume":"32","author":"I Massie","year":"2009","unstructured":"Massie, I., Selden, C., Hodgson, H. & Fuller, B. Cholesterol Reduces Supercooling and Improves Post-Warming Survival of 3D Liver Cell Spheroids for A Bioartificial Liver. International Journal Of Artificial Organs \n                           32, 413\u2013413 (2009).","journal-title":"International Journal Of Artificial Organs"},{"key":"15021_CR51","first-page":"158","volume":"32","author":"I Massie","year":"2011","unstructured":"Massie, I., Selden, C., Morris, J., Hodgson, H. & Fuller, B. Cryopreservation of encapsulated liver spheroids using a cryogen-free cooler: high functional recovery using a multi-step cooling profile. Cryo. Letters \n                           32, 158\u2013165 (2011).","journal-title":"Cryo. Letters"},{"key":"15021_CR52","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1089\/ten.tec.2010.0394","volume":"17","author":"I Massie","year":"2011","unstructured":"Massie, I., Selden, C., Hodgson, H. & Fuller, B. Cryopreservation of encapsulated liver spheroids for a bioartificial liver: reducing latent cryoinjury using an ice nucleating agent. Tissue Eng Part C. Methods \n                           17, 765\u2013774, https:\/\/doi.org\/10.1089\/ten.TEC.2010.0394 (2011).","journal-title":"Tissue Eng Part C. Methods"},{"key":"15021_CR53","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1089\/ten.tec.2013.0571","volume":"20","author":"I Massie","year":"2014","unstructured":"Massie, I. et al. GMP cryopreservation of large volumes of cells for regenerative medicine: active control of the freezing process. Tissue Eng Part C. Methods \n                           20, 693\u2013702, https:\/\/doi.org\/10.1089\/ten.TEC.2013.0571 (2014).","journal-title":"Tissue Eng Part C. Methods"},{"key":"15021_CR54","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1089\/ten.tec.2012.0307","volume":"19","author":"I Massie","year":"2013","unstructured":"Massie, I., Selden, C., Hodgson, H. & Fuller, B. Storage temperatures for cold-chain delivery in cell therapy: a study of alginate-encapsulated liver cell spheroids stored at \u221280 degrees c or \u2212170 degrees c for up to 1 year. Tissue Eng Part C. Methods \n                           19, 189\u2013195, https:\/\/doi.org\/10.1089\/ten.TEC.2012.0307 (2013).","journal-title":"Tissue Eng Part C. Methods"},{"key":"15021_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cryobiol.2016.05.013","volume":"73","author":"P Kilbride","year":"2016","unstructured":"Kilbride, P. et al. Spatial considerations during cryopreservation of a large volume sample. Cryobiology \n                           73, 47\u201354, https:\/\/doi.org\/10.1016\/j.cryobiol.2016.05.013 (2016).","journal-title":"Cryobiology"},{"key":"15021_CR56","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.cryobiol.2014.09.003","volume":"69","author":"P Kilbride","year":"2014","unstructured":"Kilbride, P. et al. A scale down process for the development of large volume cryopreservation. Cryobiology \n                           69, 367\u2013375, https:\/\/doi.org\/10.1016\/j.cryobiol.2014.09.003 (2014).","journal-title":"Cryobiology"},{"key":"15021_CR57","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00134-012-2523-2","volume":"38","author":"AJ O\u2019Brien","year":"2012","unstructured":"O\u2019Brien, A. J., Welch, C. A., Singer, M. & Harrison, D. A. Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients. Intensive Care Med \n                           38, 991\u20131000, https:\/\/doi.org\/10.1007\/s00134-012-2523-2 (2012).","journal-title":"Intensive Care Med"},{"key":"15021_CR58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","volume":"64","author":"FS Larsen","year":"2016","unstructured":"Larsen, F. S. et al. High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial. J. Hepatol \n                           64, 69\u201378, https:\/\/doi.org\/10.1016\/j.jhep.2015.08.018 (2016).","journal-title":"J. Hepatol"},{"key":"15021_CR59","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1499-3872(16)60084-X","volume":"15","author":"JJ Chen","year":"2016","unstructured":"Chen, J. J. et al. Plasma exchange-centered artificial liver support system in hepatitis B virus-related acute-on-chronic liver failure: a nationwide prospective multicenter study in China. Hepatobiliary. Pancreat. Dis. Int \n                           15, 275\u2013281 (2016).","journal-title":"Hepatobiliary. Pancreat. Dis. Int"},{"key":"15021_CR60","doi-asserted-by":"publisher","first-page":"e34127","DOI":"10.5812\/hepatmon.34127","volume":"16","author":"M Piechota","year":"2016","unstructured":"Piechota, M. & Piechota, A. An Evaluation of the Usefulness of Extracorporeal Liver Support Techniques in Patients Hospitalized in the ICU for Severe Liver Dysfunction Secondary to Alcoholic Liver Disease. Hepat. Mon \n                           16, e34127, https:\/\/doi.org\/10.5812\/hepatmon.34127 (2016).","journal-title":"Hepat. Mon"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15021-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15021-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15021-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:02:18Z","timestamp":1671782538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15021-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,6]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["15021"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-15021-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,6]]},"assertion":[{"value":"21 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14518"}}